Hayeshi, RSemete, BKalombo, LonjiKatata, LLemmer, YolandyMelariri, PNyamboli, BSwai, H2013-01-292013-01-292012Hayeshi, R, Semete, B, Kalombo, L, Katata, L, Lemmer, Y, Melariri, P, Nyamboli, B and Swai, H. 2012. Nanomedicine in the development of drugs for poverty-related diseases. Drug Discovery in Africa: Impacts of Genomics, Natural Products, Traditional Medicines, Insights into Medicinal Chemistry, and Technology Platforms in Pursuit of New Drugs. Springer-Verlag. Berlin, Germany, pp. 407-429978-3-642-28175-4978-3-642-28174-7http://link.springer.com/chapter/10.1007%2F978-3-642-28175-4_17http://hdl.handle.net/10204/6486Copyright: 2012 Springer-Verlag. This is the uncorrected proof of the chapter. The final version is published in Drug Discovery in Africa: Impacts of Genomics, Natural Products, Traditional Medicines, Insights into Medicinal Chemistry, and Technology Platforms in Pursuit of New Drugs. Springer-Verlag. Berlin, Germany, pp. 407-429, DOI 10.1007/978-3-642-28175-4_17Nanotechnology is a multidisciplinary field covering the design, manipulation, characterisation, production and application of structures, devices and systems at nanometer scale (1–500-nm-size range) which, at this size range, presents with unique or superior physicochemical properties. This scale represents the size of atoms, molecules and macromolecules. Nanomedicine is the application of nanotechnology in medical sciences for imaging, diagnosis, drug delivery (nanocarriers) and therapeutics used for treating and preventing disease.enNanomedicinePoverty-related diseasesNanotechnologyBook ChapterHayeshi, R., Semete, B., Kalombo, L., Katata, L., Lemmer, Y., Melariri, P., ... Swai, H. (2012). Nanomedicine in the development of drugs for poverty-Related diseases., <i>Workflow;10013</i> Springer-Verlag. http://hdl.handle.net/10204/6486Hayeshi, R, B Semete, Lonji Kalombo, L Katata, Yolandy Lemmer, P Melariri, B Nyamboli, and H Swai. "Nanomedicine in the development of drugs for poverty-related diseases" In <i>WORKFLOW;10013</i>, n.p.: Springer-Verlag. 2012. http://hdl.handle.net/10204/6486.Hayeshi R, Semete B, Kalombo L, Katata L, Lemmer Y, Melariri P, et al. Nanomedicine in the development of drugs for poverty-related diseases.. Workflow;10013. [place unknown]: Springer-Verlag; 2012. [cited yyyy month dd]. http://hdl.handle.net/10204/6486.TY - Book Chapter AU - Hayeshi, R AU - Semete, B AU - Kalombo, Lonji AU - Katata, L AU - Lemmer, Yolandy AU - Melariri, P AU - Nyamboli, B AU - Swai, H AB - Nanotechnology is a multidisciplinary field covering the design, manipulation, characterisation, production and application of structures, devices and systems at nanometer scale (1–500-nm-size range) which, at this size range, presents with unique or superior physicochemical properties. This scale represents the size of atoms, molecules and macromolecules. Nanomedicine is the application of nanotechnology in medical sciences for imaging, diagnosis, drug delivery (nanocarriers) and therapeutics used for treating and preventing disease. DA - 2012 DB - ResearchSpace DP - CSIR KW - Nanomedicine KW - Poverty-related diseases KW - Nanotechnology LK - https://researchspace.csir.co.za PY - 2012 SM - 978-3-642-28175-4 SM - 978-3-642-28174-7 T1 - Nanomedicine in the development of drugs for poverty-related diseases TI - Nanomedicine in the development of drugs for poverty-related diseases UR - http://hdl.handle.net/10204/6486 ER -